|Podcasts|January 28, 2022

Key Considerations for Interventional Medical Devices Undergoing First-in-Human Studies

Author(s)Avania

First-in-human (FIH) is a critical milestone for companies pursuing medical device development. Medical device developers often experience great pressure to shorten timelines and get to the clinic. However, it is important to keep certain aspects top of mind to have a successful FIH clinical experience.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Unlock Commercial Growth through Data-Driven Patient and HCP Insights Podcast
May 2nd 2025
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025
Thinking Big for Small and Mid-Sized Biotechs: How Applying Modeling and Simulation Technologies Can Improve Drug Development
January 6th 2023
The Evolving Relationship Between Sponsors and the Contract Research Organizations
December 8th 2022
The MDR: Navigating Europe’s New Standard for Medical Device Safety
October 25th 2022
The impact an eClinical Supply Chain Management platform can have on your next clinical trial
September 19th 2022

Trending on Applied Clinical Trials Online

Driving Transformation With a Connected Clinical Platform: 2025 Veeva R&D and Quality Summit Clinical Opening Keynote

AstraZeneca’s Baxdrostat Shows Promise in Phase III Trial for Hard-to-Control Hypertension

Epkinly Demonstrates Encouraging Efficacy in Phase II Trial for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Promising Trial Data Leads to Breakthrough Designation for Eli Lilly’s Investigational KRAS G12C Inhibitor in Advanced, Metastatic Non-Small Cell Lung Cancer